JURAVE

Serial Number 87201029
606

Registration Progress

Application Filed
Oct 12, 2016
Under Examination
Mar 14, 2017
Approved for Publication
Jan 17, 2017
Published for Opposition
Jan 17, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: JURAVE
Previous Owner: Glaxo Group Limited
Classes: 005

Trademark Image

JURAVE

Basic Information

Serial Number
87201029
Filing Date
October 12, 2016
Published for Opposition
January 17, 2017
Abandonment Date
October 16, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 16, 2017
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
980 Great West Road
Brentford, Middlesex TW89GS

Ownership History

Glaxo Group Limited

Original Applicant
99
Brentford, Middlesex

Glaxo Group Limited

Owner at Publication
99
Brentford, Middlesex

Legal Representation

Attorney
Angela L. Wilson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Oct 16, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Oct 16, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 14, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 28, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 12, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 18, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 15, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "JURAVE" has no meaning in a foreign language.

Classification

International Classes
005